SCIESCOPUSQ1
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
OXFORD UNIV PRESS, United Kingdom
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY is an academic journal published by OXFORD UNIV PRESS (United Kingdom). Identifiers: ISSN 1461-1457, eISSN 1469-5111. Indexed in SCIE, SCOPUS. Metrics: JIF 3.7, CiteScore 9.7, SJR 1.585, SNIP 1.27. Subject areas: CLINICAL NEUROLOGY, NEUROSCIENCES, PHARMACOLOGY & PHARMACY, PSYCHIATRY. tlooto lists 3,625 papers from this journal.
CiteScore
9.70
Métrique de citation Scopus
SJR
1.585
Classement SCImago
SNIP
1.27
Impact normalisé par source
Rang en pourcentage
-
Rang percentile du JIF
Profil de revue
- ISSN
- 1461-1457
- eISSN
- 1469-5111
- Abréviation
- INT J NEUROPSYCHOPH
- Éditeur
- OXFORD UNIV PRESS
- Pays
- United Kingdom
catégories Web of Science
SCIECLINICAL NEUROLOGY, NEUROSCIENCES, PHARMACOLOGY & PHARMACY, PSYCHIATRY
catégories ASJC de Scopus
2736 Pharmacology (medical)2738 Psychiatry and Mental Health3004 Pharmacology
Mots-clés
Clinical Neurology | Neurosciences | Pharmacology & Pharmacy | Psychiatry
Papers in this journal
Recent papers
- Three-week effect of amisulpride, aripiprazole, and olanzapine on gene expression in peripheral blood in individuals with schizophrenia spectrum disorders
2026
- Distinct therapeutic profiles of ketamine in treatment-resistant depression: an exploratory analysis
2026
- Additional Analyses Do Not Implicate Opioid Signaling in the Antidepressant Effects of Ketamine.
2026
- Structural and functional neuroimaging correlates of suicidal ideation in treatment-resistant major depressive disorder
2026
- Life engagement improvements with cariprazine in schizophrenia: a post-hoc analysis of PANSS data from short-term studies
2026
Most cited papers
- Dopamine System Dysregulation in Major Depressive Disorders
2017 · 687 citations
- Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior
2016 · 562 citations
- Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders
2020 · 447 citations
- Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
2019 · 392 citations
- BDNF Release is Required for the Behavioral Actions of Ketamine
2014 · 350 citations